1. Post-Authorisation Safety Studies (PASS): Aims of a Post-Authorisation Safety Study (PASS) | EUPATI Open Classroom

EUPATI Open Classroom

Home About Accessibility Resources EUPATI Fellows FAQ Learning Catalogue Our Impact Patient Engagement Roadmap Patient Expert Training Programme Toolbox About Open Classroom Resources EUPATI website

View

2. Aims of a Post-Authorisation Safety Study (PASS)

The main aims for initiating a PASS should include any of the following objectives:

to quantify potential or identified risks, e.g., to characterise the incidence rate, estimate the rate ratio or rate difference in comparison to a non-exposed population or a population exposed to another medicinal product, and investigate risk factors, including effect modifiers;

to evaluate the risks of a medicinal product used in a patient population for which safety information is limited or missing (e.g., pregnant women, specific age groups);

to evaluate the risks of a medicinal product after long-term use;

to provide evidence about the absence of risks;

to assess patterns of medicines utilisation that add knowledge regarding its safety or appropriateness of risk management measures (e.g. information on indication, off-label use, dosage, co-medication or medication errors in clinical practice);